Flupenthixol and Melitracen in the management of trigeminal neuralgia.
Twelve patients with trigeminal neuralgia were treated with a daily dose of 2 mg Melitracen and 40 mg Flupenthixol. The majority of patients derived benefit from it. The former drug is a bipolar thymoeleptic and the latter a neuroleptic. There was no adverse side effects. The regime of treatment is recommended in cases that do not respond to conventional treatment.
D000873:Anthracenes / Q000627:therapeutic use*; D005475:Flupenthixol / Q000627:therapeutic use*; D006801:Humans; D013892:Thioxanthenes / Q000627:therapeutic use*; D014277:Trigeminal Neuralgia / Q000188:drug therapy*
D000873:Anthracenes; D013892:Thioxanthenes; C005100:melitracene; D005475:Flupenthixol